PURPOSE: The goal of this study was to identify new candidate genes and genomic copy-number variations associated with a rare, severe, and persistent speech disorder termed childhood apraxia of speech. Childhood apraxia of speech is the speech disorder segregating with a mutation in FOXP2 in a multigenerational London pedigree widely studied for its role in the development of speech-language in humans. METHODS: A total of 24 participants who were suspected to have childhood apraxia of speech were assessed using a comprehensive protocol that samples speech in challenging contexts. All participants met clinical-research criteria for childhood apraxia of speech. Array comparative genomic hybridization analyses were completed using a customized 385K Nimblegen array (Roche Nimblegen, Madison, WI) with increased coverage of genes and regions previously associated with childhood apraxia of speech. RESULTS: A total of 16 copy-number variations with potential consequences for speech-language development were detected in 12 or half of the 24 participants. The copy-number variations occurred on 10 chromosomes, 3 of which had two to four candidate regions. Several participants were identified with copy-number variations in two to three regions. In addition, one participant had a heterozygous FOXP2 mutation and a copy-number variation on chromosome 2, and one participant had a 16p11.2 microdeletion and copy-number variations on chromosomes 13 and 14. CONCLUSION: Findings support the likelihood of heterogeneous genomic pathways associated with childhood apraxia of speech.
PURPOSE: The goal of this study was to identify new candidate genes and genomic copy-number variations associated with a rare, severe, and persistent speech disorder termed childhood apraxia of speech. Childhood apraxia of speech is the speech disorder segregating with a mutation in FOXP2 in a multigenerational London pedigree widely studied for its role in the development of speech-language in humans. METHODS: A total of 24 participants who were suspected to have childhood apraxia of speech were assessed using a comprehensive protocol that samples speech in challenging contexts. All participants met clinical-research criteria for childhood apraxia of speech. Array comparative genomic hybridization analyses were completed using a customized 385K Nimblegen array (Roche Nimblegen, Madison, WI) with increased coverage of genes and regions previously associated with childhood apraxia of speech. RESULTS: A total of 16 copy-number variations with potential consequences for speech-language development were detected in 12 or half of the 24 participants. The copy-number variations occurred on 10 chromosomes, 3 of which had two to four candidate regions. Several participants were identified with copy-number variations in two to three regions. In addition, one participant had a heterozygous FOXP2 mutation and a copy-number variation on chromosome 2, and one participant had a 16p11.2 microdeletion and copy-number variations on chromosomes 13 and 14. CONCLUSION: Findings support the likelihood of heterogeneous genomic pathways associated with childhood apraxia of speech.
Authors: Beate Peter; Wendy H Raskind; Mark Matsushita; Mark Lisowski; Tiffany Vu; Virginia W Berninger; Ellen M Wijsman; Zoran Brkanac Journal: J Neurodev Disord Date: 2010-11-09 Impact factor: 4.025
Authors: T Wakioka; A Sasaki; R Kato; T Shouda; A Matsumoto; K Miyoshi; M Tsuneoka; S Komiya; R Baron; A Yoshimura Journal: Nature Date: 2001-08-09 Impact factor: 49.962
Authors: Michele P Kelly; Sheree F Logue; Julie Brennan; Jonathon P Day; Subha Lakkaraju; Lixin Jiang; Xiaotian Zhong; May Tam; Stacey J Sukoff Rizzo; Brian J Platt; Jason M Dwyer; Sarah Neal; Virginia L Pulito; Michael J Agostino; Steven M Grauer; Rachel L Navarra; Cody Kelley; Thomas A Comery; Richard J Murrills; Miles D Houslay; Nicholas J Brandon Journal: Proc Natl Acad Sci U S A Date: 2010-04-19 Impact factor: 11.205
Authors: Elizabeth Spiteri; Genevieve Konopka; Giovanni Coppola; Jamee Bomar; Michael Oldham; Jing Ou; Sonja C Vernes; Simon E Fisher; Bing Ren; Daniel H Geschwind Journal: Am J Hum Genet Date: 2007-10-31 Impact factor: 11.025
Authors: E Bacchelli; F Blasi; M Biondolillo; J A Lamb; E Bonora; G Barnby; J Parr; K S Beyer; S M Klauck; A Poustka; A J Bailey; A P Monaco; E Maestrini Journal: Mol Psychiatry Date: 2003-11 Impact factor: 15.992
Authors: Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev Journal: Nat Methods Date: 2010-04 Impact factor: 28.547
Authors: Anghelus Ostroveanu; Eddy A van der Zee; Ulrich L M Eisel; Martina Schmidt; Ingrid M Nijholt Journal: Hippocampus Date: 2010-09 Impact factor: 3.899
Authors: B S Abrahams; D Tentler; J V Perederiy; M C Oldham; G Coppola; D H Geschwind Journal: Proc Natl Acad Sci U S A Date: 2007-10-31 Impact factor: 11.205
Authors: Sonja C Vernes; Dianne F Newbury; Brett S Abrahams; Laura Winchester; Jérôme Nicod; Matthias Groszer; Maricela Alarcón; Peter L Oliver; Kay E Davies; Daniel H Geschwind; Anthony P Monaco; Simon E Fisher Journal: N Engl J Med Date: 2008-11-05 Impact factor: 91.245
Authors: Lawrence D Shriberg; Edythe A Strand; Marios Fourakis; Kathy J Jakielski; Sheryl D Hall; Heather B Karlsson; Heather L Mabie; Jane L McSweeny; Christie M Tilkens; David L Wilson Journal: J Speech Lang Hear Res Date: 2017-04-14 Impact factor: 2.297
Authors: Kristen M Allison; Claire Cordella; Jenya Iuzzini-Seigel; Jordan R Green Journal: J Speech Lang Hear Res Date: 2020-08-12 Impact factor: 2.297